Analyst Michael Matson from Needham maintained a Buy rating on Hologic (HOLX – Research Report) and keeping the price target at $90.00.Pick the ...

Matson covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Boston Scientific, and TransMedics Group. Currently, the analyst consensus on Merit Medical Systems is a Strong ...

Matson Money's track record as a steward is mixed, leading to an Average Parent Pillar rating. Portfolio management turnover has been minimal at the firm over the past five years. Long-term ...

Here is how C.H. Robinson Worldwide (CHRW) and Matson (MATX) have performed compared to their sector so far this year. Matson currently trades at $146.22 and has been a dream stock for shareholders.